LSII Trademark

Trademark Overview


On Friday, April 19, 2019, a trademark application was filed for LSII with the United States Patent and Trademark Office. The USPTO has given the LSII trademark a serial number of 88393497. The federal status of this trademark filing is REGISTERED as of Tuesday, March 23, 2021. This trademark is owned by Life Science Institute, Inc.. The LSII trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical use; Stem cells for medical use; Pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries
lsii

General Information


Serial Number88393497
Word MarkLSII
Filing DateFriday, April 19, 2019
Status700 - REGISTERED
Status DateTuesday, March 23, 2021
Registration Number6297838
Registration DateTuesday, March 23, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 5, 2021

Trademark Statements


Goods and ServicesCells for medical use; Stem cells for medical use; Pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries
Pseudo MarkLIFE SCIENCE INSTITUTE INC

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 6, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLife Science Institute, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 100-0005
JP

Party NameLife Science Institute, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 100-0005
JP

Party NameLife Science Institute, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 100-0005
JP

Trademark Events


Event DateEvent Description
Tuesday, March 23, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, January 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 30, 2020ELECTRONIC RECORD REVIEW COMPLETE
Friday, November 27, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, November 23, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 19, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 19, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 30, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, July 30, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, July 30, 2020INQUIRY TO SUSPENSION E-MAILED
Thursday, July 30, 2020SUSPENSION INQUIRY WRITTEN
Wednesday, July 29, 2020LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, January 14, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 14, 2020LETTER OF SUSPENSION E-MAILED
Tuesday, January 14, 2020SUSPENSION LETTER WRITTEN
Thursday, January 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 9, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 6, 2020ASSIGNED TO LIE
Thursday, December 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 3, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 3, 2019NON-FINAL ACTION E-MAILED
Wednesday, July 3, 2019NON-FINAL ACTION WRITTEN
Friday, June 28, 2019ASSIGNED TO EXAMINER
Monday, May 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 23, 2019NEW APPLICATION ENTERED IN TRAM